期刊文献+

miR-195与乳腺癌侵袭及预后的关系 被引量:4

Correlation of miR-195 with invasiveness and prognosis of breast cancer
原文传递
导出
摘要 目的检测乳腺癌石蜡包埋组织中miR-195的表达,分析其与临床病理参数以及预后的关系。方法采用real-time PCR对88例乳腺癌患者原发肿瘤蜡块提取的RNA进行miR-195表达水平的测定,Mann Whitney-U非参数检验比较miR-195表达水平和乳腺癌临床病理参数的关系,采用Kaplan-Meier生存分析和Log-rank检验进行预后分析,Cox回归分析进行单因素、多因素分析。结果在高组织学分级、肿瘤大(134)、淋巴结转移及伴有脉管瘤栓的乳腺癌中miR-195表达水平相应地比低组织学分级(Z=-2.271,P=0.023)、肿瘤小(T1-2)(Z=-2.687,P=0.007)、无淋巴结转移(Z=-1.967,P=0.049)及无脉管瘤栓(Z=-2.432,P=0.015)的乳腺癌下调。miR-195水平与雌激素受体/孕激素受体/HER-2表达、肿瘤TNM分期、是否复发、组织学类型及月经状态等未见明显关联(P〉0.05)。以中位数2^-ACt=0.270为界,Kaplan-Meier生存分析表明,miR-195表达水平与乳腺癌的无复发生存率(X^2=5.985,P=0.014)或总生存率(X^2=30.050,P=0.000)呈正相关。Cox回归多因素分析显示,miR-195(HR=0.040,95%CI:0.009-0.179,P=0.000)、组织学分级(HR=8.360,95%CI:2.25-31.00,P=0.001)、雌激素受体表达(HR=0.220,95%C1:0.06-0.80,P=0.022)及复发状态(HR=6.860,95%CI:l.70-27.60,P:0.007)是独立的预后因子。结论miR-195在乳腺癌组织的表达水平与组织学高级别、肿瘤大(13-4)、淋巴结转移、脉管瘤栓形成呈负相关。miR-195表达与乳腺癌预后相关。 Objective To explore the potential role of miR-195 on invasiveness and prognosis of breast cancer. Methods The RNA in formalin-fixed paraffin embedded (FFPE) of 88 breast cancer patients with primary tumors was extracted, and miR-195 levels were quantified by quantitative real-time polymerase chain reaction (real-time PCR). The relationship of miR-195 levels and clinicopathologieal variables were assessed by Mann Whitney-U test. Recurrence-free survival and overall survival curves were derived from Kaplan-Meier estimates and the curves were compared by Log-rank tests. Cox regression analysis was used for multivariate analysis. All statistical tests were two-sided. Results The levels of miR- 195 in the breast cancer with histological high grade, tumor size of T3-4, lymph nodal involvement or vessel invasion were significantly down-regulated, compared with those of patients with histological low grade ( Z = - 2. 271, P = 0. 023 ), tumor size of T1-2 ( Z = - 2. 687, P = 0. 007 ), no lymph node metastasis ( Z = - 1. 967, P = 0. 049 ) and vessel invasion ( Z = - 2. 432, P = 0. 015 ). In addition, no statistically significant difference (P 〉 0. 05 ) was identified between miR-195 levels and hormone receptors status, HER-2 expression, TNM stage, tumor types, recurrence and menstrual status. When considering 2^-ACt = 0. 270 ( median level) as cut-off value, Kaplan-Meier survival analysis indicated that patients with high miR- 195 level showed a positive association towards a longer survival, either recurrence-free survival (X^2 = 5.985, P=0. O14) or overall survival (X^2 = 30.05, P =0.000). In a multivariate analysis, miR-195 expression on FFPE correlated significantly with outcomes of breast cancer ( HR = 0. 040, 95% CI:0. 009- 0. 179, P = 0. 000) and was independent of other prognostic factors. Conclusions It suggests that miR-195expression on FFPE is inversely correlated with histological high grade, bigger tumor size, lymph node involvement, vessel invasion. Furthermore
出处 《中华外科杂志》 CAS CSCD 北大核心 2012年第4期353-356,共4页 Chinese Journal of Surgery
基金 福建省教育厅基金资助项目(JAlll20) 福建省自然科学基金资助项目(2006J0096)
关键词 乳腺肿瘤 肿瘤浸润 微RNAS 预后 Breast neoplasms Neoplasm invasiveness MicroRNAs Prognosis
  • 相关文献

参考文献9

  • 1Bushati N,Cohen SM. microRNA functions[J].Annual Review of Cell and Developmental Biology,2007,(0):175-205.doi:10.1146/annurev.cellbio.23.090506.123406. 被引量:1
  • 2Garzon R,Calin GA,Croce CM. MicroRNAs in Cancer[J].Annual Review of Medicine,2009.167-179.doi:10.1146/annurev.med.59.053006.104707. 被引量:1
  • 3Li J,Smyth P,Flavin R. Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin embedded(FFPE)cells and snap frozen cells[J].BMC Biotechnology,2007.36.doi:10.1186/1472-6750-7-36. 被引量:1
  • 4Heneghan HM,Miller N,Lowery AJ. Circulating mieroRNAs as novel minimally invasive biomarkers for breast cancer[J].Annals of Surgery,2010.499-505.doi:10.1097/SLA.0b013e3181cc939f. 被引量:1
  • 5张辉,苏式兵,周钱梅,陆亦宇.乳腺癌细胞与乳腺上皮细胞MicroRNAs表达谱的差异性分析[J].癌症,2009,28(5):493-499. 被引量:8
  • 6Li D,Zhao Y,Liu C. Analysis of MiR-195 and MiR-497expression,regulation and role in breast cancer[J].Clinical Cancer Research,2011.1722-1730. 被引量:1
  • 7Xu T,Zhu Y,Xiong Y. MicroRNA 195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells[J].Hepatology,2009.113-121. 被引量:1
  • 8Liu L,Chen L,Xu Y. microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells[J].Biochemical and Biophysical Research Communications,2010.236-240. 被引量:1
  • 9Soon PS,Tacon LJ,Gill AJ. miR-195 and miR-483-5pidentified as predictors of poor prognosis in adrenocortical cancer[J].Clinical Cancer Research,2009.7684-7692.doi:10.1158/1078-0432.CCR-09-1587. 被引量:1

二级参考文献21

  • 1廖荣霞,孙建国,张亮,陈敏,陈彬,娄桂予,周度金,陈正堂.乳腺癌miRNAs表达谱检测及初步分析[J].第三军医大学学报,2006,28(22):2209-2212. 被引量:11
  • 2Lee Y, Kim M, Han J, et al. MicroRNA genes are transcribed by RNA polymerase Ⅱ [J]. EMBO J, 2004,23 (20) :4051-4060. 被引量:1
  • 3Berezikov E, Guryev V, van de Belt J, et al. Phylogenetic shadowing and computational identification of human microRNA genes [J]. Cell, 2005,120( 1 ) : 21-24. 被引量:1
  • 4Xie X, Lu J, Kulbokas E J, et al. Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals [J]. Nature, 2005,434(7031 ) : 338-345. 被引量:1
  • 5Zamore PD, Haley B. Ribo-gnome: the big world of small RNAs [J]. Science, 2005,309(5740) : 1519-1524. 被引量:1
  • 6Bishop JM. Molecular themes in oncogenesis [J]. Cell, 1991 64(2) : 235-248. 被引量:1
  • 7Weinberg RA. Tumor suppressor genes [J]. Science, 1991, 254(5035) : 1138-1146. 被引量:1
  • 8Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer [J]. Cancer Res, 2005,65 (16) : 7065-7070. 被引量:1
  • 9Vivien W, Wei W. MicroRNA: a new player in breast cancer development [ J ]. Cancer Mol, 2007,3 ( 5 ) : 133-138. 被引量:1
  • 10Choi Y, Qin Y, Berger MF, et al. Microarray analyses of newborn mouse ovaries lacking nobox [J]. Biol Reprod, 2007,77(2) :312-319. 被引量:1

共引文献7

同被引文献32

  • 1Wei Liu Sheng-Yong Mao Wei-Yun Zhu.Impact of tiny miRNAs on cancers[J].World Journal of Gastroenterology,2007,13(4):497-502. 被引量:18
  • 2LEE RC,FEINBAUM RL,AMBROS V. The C.elegans hetcrochronic gene lin-4 encodes small RNA with antisense complementarity to lin-14[J].Cell,1993,(05):843-854. 被引量:1
  • 3ALVAREZ-GARCIA I,MISKA EA. MicroRNA functions in animal development and human disease[J].Development,2005,(21):4653-4662.doi:10.1242/dev.02073. 被引量:1
  • 4WIEMER EAC. The role of microRNAs in cancer:No small matter[J].European Journal of Cancer,2007.1529-1544. 被引量:1
  • 5MELO SA,ESTELLER M. Dysregulation of microRNAs in cancer:Playing with fire[J].FEBS Letters,2011.2087-2999. 被引量:1
  • 6HAYASHITA Y,OSADA H,TATEMATSU Y. A polycistronic microRNA cluster,miR-17-92,is overexpressed in human lung cancers and enhances cell proliferation[J].Cancer Research,2006,(21):9628-9632. 被引量:1
  • 7EIS PS,TAM W,SUN L. Accumulation of miR-155 and BIC RNA in human B cell lymphomas[J].Proceedings of the National Academy of Sciences(USA),2005,(10):3627-3632.doi:10.1073/pnas.0500613102. 被引量:1
  • 8LOFFLER D,BROCKE-HEIDRICH K,PFEIFER G. Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microR-21 through a highly conserved enhancer[J].Blood,2007,(04):1330-1333. 被引量:1
  • 9CIMMINO A,CALIN GA,FABBRI M. MiR-15 and miR-16 induce apoptosis by targeting BCL2[J].Proceedings of the National Academy of Sciences(USA),2005,(39):13944-13949.doi:10.1073/pnas.0506654102. 被引量:1
  • 10IORIO MV,FERRACIN M,LIU CG. MicroRNA gene expression deregulation in human breast cancer[J].Cancer Research,2005,(16):7065-7070. 被引量:1

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部